High-Dose Ifosfamide Chemotherapy in a Series of Patients Affected by Myxoid Liposarcoma

<div>Overall survival (OS) of patients treated with high-dose prolonged-infusion ifosfamide chemotherapy (11 patients). Median OS was 37 months.</div>

Sarcoma

fig2

Figure 2

Figure 2: High-Dose Ifosfamide Chemotherapy in a Series of Patients Affected by Myxoid Liposarcoma 